GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of unpopular opinion: most of what gets said here about Canada is guesswork — 58 comments in the full submission. View in context.
1.2k
c/glp1canada·submitted 8 months ago by u/food_noise_gone

unpopular opinion: most of what gets said here about Canada is guesswork

Formularybranch of 6 comments

Thinking out loud about this: unpopular opinion: most of what gets said here about Canada is guesswork. Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing. Nothing here is medical or legal advice. The…

Read the full submission and all 58 comments →

This branch

6 comments, started 8 months ago
u/isabela_guerrero62 points·8 months ago

Yes. Cash prices vary and comparing them before assuming coverage is the only route is worth doing.

replysharereportpermalink
u/ahmed_rasmussen42 points·8 months ago

ask the pharmacy what the cash price is, it varies

replysharereportpermalink
u/anders_karlsen26 points·8 months ago

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.

replysharereportpermalink
u/dario_vermeulen21 points·8 months ago

the exception drug status route exists in several provinces

replysharereportpermalink
u/rina_nascimento21 points·8 months ago

Small fix — that formulary position is another province’s and does not apply here.

replysharereportpermalink
u/sequence_checkerresearch peptides13 points·8 months ago

formulary decisions are provincial, so the province is the first fact

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.